Why Investors Need to Take Advantage of These 2 Oils and Energy Stocks Now — Positive
EOG MPC Zacks Investment Research — July 16, 2025The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Here Is Why Bargain Hunters Would Love Fast-paced Mover Cushman & Wakefield (CWK) — Positive
CWK Zacks Investment Research — July 16, 2025If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Cushman & Wakefield (CWK) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Here's Why Momentum in DXP Enterprises (DXPE) Should Keep going — Positive
DXPE Zacks Investment Research — July 16, 2025If you are looking for stocks that are well positioned to maintain their recent uptrend, DXP Enterprises (DXPE) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar — Positive
INSP VRTX Zacks Investment Research — July 16, 2025Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Why Investors Need to Take Advantage of These 2 Finance Stocks Now — Positive
CB LMND Zacks Investment Research — July 16, 2025The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar — Positive
FRPT MDLZ Zacks Investment Research — July 16, 2025Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
These 2 Basic Materials Stocks Could Beat Earnings: Why They Should Be on Your Radar — Positive
ATI PAAS Zacks Investment Research — July 16, 2025Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Nvidia's $4T market cap is justified by new growth opportunities, not just past performance—it's not too late to invest. Resumed H20 GPU sales to China and global open-source AI trends massively expand Nvidia's addressable market and revenue potential. Major partnerships in Saudi Arabia and UAE, plus quantum computing initiatives, provide long-term catalysts and runway for growth.
Will Increased Expenses Affect Bristol Myers' Performance? — Negative
BMY Zacks Investment Research — July 16, 2025BMY inks $3.5B bispecific antibody deal with BioNTech as top-line pressures and bottom-line risks mount.
HWC Q2 Earnings Beat Estimates on NII & Fee Income Growth, Stock Down — Positive
HWC Zacks Investment Research — July 16, 2025HWC tops Q2 estimates with EPS of $1.37, but shares dip 3.2% as deposit declines and credit costs weigh on results.
BILL's Platform-Led Momentum Builds: Can AI Initiatives Boost Growth? — Positive
BILL Zacks Investment Research — July 16, 2025BILL gains momentum as AI-powered financial tools drive platform adoption despite a sharp year-to-date share decline.
3 High-Risk, High-Reward Stocks With Explosive Upside — Positive
AUR CYBN RZLV MarketBeat — July 16, 2025Investors hunting for firms with massive growth potential often look to trending industries, which are primed to benefit from near-term hype and, in many cases, an influx of demand and capital.
Data Center Demand is Rising: Can it Fuel Further Upside to APH Stock? — Positive
APH Zacks Investment Research — July 16, 2025Data center strength lifts Amphenol as its high-speed interconnects and thermal solutions anchor future growth.
Meta Platforms (NASDAQ: META) Price Prediction and Forecast 2025-2030 for July 16 — Positive
META 24/7 Wall Street — July 16, 2025Shares of Meta Platforms Inc. (NASDAQ: META) lost 3.03% over the past five trading sessions, but the Magnificent Seven mainstay remains up 18.38% year-to-date.
Johnson Fistel Begins Investigation on Behalf of BellRing Brands, Inc. (BRBR) Shareholders — Neutral
BRBR GlobeNewsWire — July 16, 2025SAN DIEGO, July 16, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP, is investigating whether BellRing Brands, Inc. (NYSE: BRBR), or any of its executive officers, violated securities laws by misrepresenting or failing to timely disclose material information to investors.
OKYO Pharma reports positive Phase 2 results for urcosimod in neuropathic corneal pain — Positive
OKYO Proactive Investors — July 16, 2025OKYO Pharma Ltd (NASDAQ:OKYO) on Wednesday reported promising top-line results from a Phase 2 trial of its investigational drug urcosimod for neuropathic corneal pain (NCP), with 75% of patients showing greater than 80% pain reduction after 12 weeks of treatment. Patients treated with the 0.05% formulation of urcosimod saw a statistically significant reduction in pain scores compared to baseline, as measured by the Visual Analogue Scale (VAS), with an average improvement of 5.5 points versus 2.75 in the placebo group.
Nvidia CEO Jensen Huang sells another $37 million worth of stock — Neutral
NVDA CNBC — July 16, 2025Nvidia CEO Jensen Huang sold another 225,000 shares of the chipmaker, totaling about $37 million, according to an SEC filing. The sale comes as part of a plan adopted in March for Huang to sell up to 6 million shares of the leading artificial intelligence company.
Should You Continue to Hold Veracyte Stock in Your Portfolio Now? — Negative
VCYT Zacks Investment Research — July 16, 2025VCYT's Decipher growth and strong cash position bolster its outlook, but Biopharma headwinds and macro risks loom.
How Will AbbVie's Oncology Drugs Aid Upcoming Q2 Results? — Negative
ABBV Zacks Investment Research — July 16, 2025ABBV's oncology sales might have dipped in Q2 as gains from newer drugs face pressure from Imbruvica's ongoing decline.
Can VRT's Strong Global Ties Drive Further Upside for the Stock? — Positive
VRT Zacks Investment Research — July 16, 2025Vertiv's AI-focused alliances drive growth across power, cooling and infrastructure in high-density deployments.
